Change of CFO at Johnson & Johnson

After 19 years with the US healthcare giant Johnson & Johnson (NYSE: JNJ), Dominic Caruso, executive vice president, chief financial officer, has elected to retire in September 2018. Mr Caruso was named CFO in 2007, and served as CFO longer than anyone in the company’s 132- year history.

"During his nearly 12 years as CFO, Dominic provided Credo-based leadership and financial stewardship through the economic downturn and was instrumental in helping the company deliver significant gains over the past five years," said Alex Gorsky, chairman and chief executive of Johnson & Johnson.

Under Mr Caruso’s leadership, the company completed three of its largest acquisitions: Actelion, Synthes and Pfizer Consumer Health. He was also instrumental in driving growth and capital allocation strategies that led Johnson & Johnson to exceed our competitor composite, as well as most major indices, for total shareholder return in 2017 and over the last three-, five-, ten- and twenty-year periods.